OPKO Health Free Cash Flow 2010-2023 | OPK
OPKO Health Annual Free Cash Flow | |
---|---|
2023 | -41.76 |
2022 | -117.82 |
2021 | 72.21 |
2020 | 6.04 |
2019 | -184.59 |
2018 | -135.78 |
2017 | -131.33 |
2016 | 14.90 |
2015 | 153.18 |
2014 | -95.11 |
2013 | -58.98 |
2012 | -26.89 |
2011 | -20.45 |
2010 | -19.49 |
2009 | -23.58 |
OPKO Health Quarterly Free Cash Flow | |
---|---|
2023-12-31 | -41.76 |
2023-09-30 | -2.05 |
2023-06-30 | -31.22 |
2023-03-31 | -25.36 |
2022-12-31 | -117.82 |
2022-09-30 | -80.31 |
2022-06-30 | -41.09 |
2022-03-31 | -24.76 |
2021-12-31 | 72.21 |
2021-09-30 | 84.53 |
2021-06-30 | -7.44 |
2021-03-31 | 16.85 |
2020-12-31 | 6.04 |
2020-09-30 | -21.48 |
2020-06-30 | -74.88 |
2020-03-31 | -48.99 |
2019-12-31 | -184.59 |
2019-09-30 | -134.80 |
2019-06-30 | -108.74 |
2019-03-31 | -51.92 |
2018-12-31 | -135.78 |
2018-09-30 | -98.24 |
2018-06-30 | -63.27 |
2018-03-31 | -40.95 |
2017-12-31 | -131.33 |
2017-09-30 | -122.27 |
2017-06-30 | -69.99 |
2017-03-31 | -40.36 |
2016-12-31 | 14.90 |
2016-09-30 | -14.19 |
2016-06-30 | 21.48 |
2016-03-31 | -19.02 |
2015-12-31 | 153.18 |
2015-09-30 | 168.95 |
2015-06-30 | 203.30 |
2015-03-31 | 238.43 |
2014-12-31 | -95.11 |
2014-09-30 | -68.22 |
2014-06-30 | -45.68 |
2014-03-31 | -23.47 |
2013-12-31 | -58.98 |
2013-09-30 | -31.96 |
2013-06-30 | -8.61 |
2013-03-31 | -15.50 |
2012-12-31 | -26.89 |
2012-09-30 | -20.75 |
2012-06-30 | -18.17 |
2012-03-31 | -11.67 |
2011-12-31 | -20.45 |
2011-09-30 | -13.16 |
2011-06-30 | -9.11 |
2011-03-31 | -4.79 |
2010-12-31 | -19.49 |
2010-09-30 | -17.86 |
2010-06-30 | -11.80 |
2010-03-31 | -2.88 |
2009-12-31 | -23.58 |
2009-09-30 | -20.12 |
2009-06-30 | -15.04 |
2009-03-31 | -8.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.910B | $0.864B |
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $227.045B | 27.51 |
Intuitive Surgical (ISRG) | United States | $136.272B | 82.09 |
Edwards Lifesciences (EW) | United States | $52.101B | 33.91 |
DexCom (DXCM) | United States | $50.096B | 75.89 |
Alcon (ALC) | Switzerland | $44.024B | 31.55 |
IDEXX Laboratories (IDXX) | United States | $43.037B | 50.45 |
IQVIA Holdings (IQV) | United States | $42.114B | 24.43 |
STERIS (STE) | Ireland | $23.320B | 27.25 |
Waters (WAT) | United States | $21.295B | 31.30 |
SONOVA HOLDING (SONVY) | Switzerland | $18.860B | 0.00 |
Hologic (HOLX) | United States | $17.655B | 19.75 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $12.898B | 15.06 |
ShockWave Medical (SWAV) | United States | $12.427B | 77.34 |
Sysmex ADR (SSMXY) | Japan | $10.938B | 34.30 |
Teleflex (TFX) | United States | $10.015B | 15.59 |
Globus Medical (GMED) | United States | $8.507B | 24.94 |
Penumbra (PEN) | United States | $8.091B | 91.95 |
Masimo (MASI) | United States | $6.118B | 35.24 |
Glaukos (GKOS) | United States | $5.589B | 0.00 |
TransMedics (TMDX) | United States | $4.362B | 413.88 |
Integer Holdings (ITGR) | United States | $3.753B | 22.67 |
PROCEPT BioRobotics (PRCT) | United States | $3.359B | 0.00 |
LivaNova (LIVN) | United Kingdom | $3.327B | 19.75 |
Elekta AB (EKTAY) | Sweden | $2.883B | 19.78 |
Tandem Diabetes Care (TNDM) | United States | $2.846B | 0.00 |
Inari Medical (NARI) | United States | $2.645B | 0.00 |
Nihon Kohden (NHNKY) | Japan | $2.489B | 21.05 |
RxSight (RXST) | United States | $2.227B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $2.083B | 9.09 |
Veracyte (VCYT) | United States | $1.760B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.521B | 0.00 |
Artivion (AORT) | United States | $0.977B | 93.76 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.922B | 17.94 |
Silk Road Medical (SILK) | United States | $0.832B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.746B | 0.00 |
Paragon 28 (FNA) | United States | $0.659B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.637B | 21.63 |
Pacific Biosciences Of California (PACB) | United States | $0.607B | 0.00 |
SiBone (SIBN) | United States | $0.604B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.566B | 0.00 |
IRadimed (IRMD) | United States | $0.536B | 29.99 |
Pulse Biosciences (PLSE) | United States | $0.425B | 0.00 |
Nevro (NVRO) | United States | $0.363B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.324B | 11.08 |
Treace Medical Concepts (TMCI) | United States | $0.310B | 0.00 |
Sight Sciences (SGHT) | United States | $0.271B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.256B | 0.00 |
AxoGen (AXGN) | United States | $0.252B | 0.00 |
AngioDynamics (ANGO) | United States | $0.247B | 0.00 |
908 Devices (MASS) | United States | $0.247B | 0.00 |
NeuroPace (NPCE) | United States | $0.245B | 0.00 |
Inogen (INGN) | United States | $0.210B | 0.00 |
Delcath Systems (DCTH) | United States | $0.196B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.194B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.184B | 0.00 |
CVRx (CVRX) | United States | $0.167B | 0.00 |
Semler Scientific (SMLR) | United States | $0.166B | 8.42 |
ClearPoint Neuro (CLPT) | United States | $0.165B | 0.00 |
Accuray (ARAY) | United States | $0.159B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.106B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.101B | 0.00 |
Yubo Biotech (YBGJ) | China | $0.100B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.087B | 18.28 |
Neuronetics (STIM) | United States | $0.072B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.064B | 0.00 |
SEP Acquisition (SEPA) | United States | $0.064B | 0.00 |
Hyperfine (HYPR) | United States | $0.063B | 0.00 |
Envoy Medical (COCH) | United States | $0.060B | 0.00 |
InspireMD (NSPR) | Israel | $0.059B | 0.00 |
DarioHealth (DRIO) | United States | $0.051B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.051B | 0.00 |
Vasomedical (VASO) | United States | $0.050B | 9.00 |
Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.048B | 0.00 |
LENSAR (LNSR) | United States | $0.045B | 0.00 |
ReWalk Robotics (LFWD) | Israel | $0.044B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.037B | 0.00 |
Precision Optics (POCI) | United States | $0.037B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.036B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.035B | 0.00 |
Spectral AI (MDAI) | United States | $0.030B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.028B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.026B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.023B | 0.00 |
PAVmed (PAVM) | United States | $0.021B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.018B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.018B | 0.00 |
NexGel (NXGL) | United States | $0.014B | 0.00 |
Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
Avinger (AVGR) | United States | $0.006B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
Tenon Medical (TNON) | United States | $0.004B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Dynatronics (DYNT) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Nuwellis (NUWE) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |